Neurocrine Biosciences
NBIX
#1550
Rank
NZ$23.70 B
Marketcap
NZ$237.75
Share price
2.37%
Change (1 day)
-10.36%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company